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 47 
To the Editor:  48 
The filaggrin gene (FLG) is essential for skin differentiation and epidermal barrier 49 
formation. FLG loss-of-function (LoF) variants are associated with ichthyosis vulgaris (IV) and 50 
the major genetic risk factor for developing atopic dermatitis (AD)1-3. Genetic stratification of 51 
AD patients according to FLG LoF risk is a common practice for both research and clinical 52 
studies however few studies comprehensively sequence the entire FLG coding region. The 53 
majority of studies that include FLG genotyping have screened for common predominant LoF 54 
variants to report allele frequencies after full Sanger-sequencing of a smaller batch of test patient 55 
samples or previous published data. This strategy potentially results in under-reporting of the 56 
genetic contribution especially in ethnicities where FLG LoF variants are highly diverse4. 57 
Distinct LoF variants have been reported for the majority of ethnicities studied to date. For 58 
example, two predominant sequence variants (p.R501X and c.2282del4) make up approximately 59 
80% of the mutation burden in northern Europeans5, whereas in East Asian ethnicities, a larger 60 
FLG LoF mutation spectrum is found with fewer predominating variants6, 7. However, routinely 61 
Sanger-sequencing the entire FLG coding region for large cohorts is not always feasible, 62 
although desirable as it is essential to correctly stratify patients. To address this we developed a 63 
robust and cost-effective high-throughput PCR-based method for analysing the entire coding 64 
region of FLG using Fluidigm microfluidics technology and next-generation sequencing (NGS). 65 
We have applied this method to fully resequence cohorts of Chinese, Malay and Indian AD 66 













We designed and optimized overlapping FLG-specific primer assays (containing NGS 68 
sequencing adapters) to span the entire FLG coding region including known intragenic copy 69 
number variation (CNV) (See Figure 1A and Table E1 in the Online Repository). 48 overlapping 70 
primer assays, with amplicons of maximum 500 base pairs, provided redundancy for sequencing 71 
reads across primer binding sites and 100% coverage of FLG exon bases (see Figure 1B). The 72 
Fluidigm Access Array 48.48 integrated fluidic circuit (IFC) chip (Fluidigm, US), generates 48 73 
amplicons for 48 different DNA samples in parallel, simultaneously thermocycling 2304 PCR 74 
reactions at nanolitre volumes (See Figure E1 and Supplemental Methods in the Online 75 
Repository). Initially 96 DNA samples were assayed in IFC chips prior to Illumina MiSeq 2x250 76 
bp read mode (4 samples failed). 14 samples from this batch of 96 were previously Sanger 77 
sequenced for the entire FLG coding region5, 7. The known FLG LoF variant profile was then 78 
used to validate LoF variant detection with the IFC and NGS method. We identified all FLG LoF 79 
variants originally identified by Sanger in the 14 samples as well as additional variants in two 80 
samples (see Table 1) and documented LoF variants in the remaining 78 samples that passed 81 
quality control testing (see Table E2 in the Online Repository). LoF variants were all confirmed 82 
by visual inspection using Integrated Genome Viewer before Sanger sequencing. Additionally 83 
we determined the FLG CNV of repeats 8 and 10 (an important risk factor for AD8) in the 92 84 
samples using relative coverage based metrics (see Figure E2 in the Online Repository).  85 
The IFC and NGS sequencing method was then used to analyse a further 334 Singapore 86 
IV and/or AD patient samples to obtain estimates of disease-associated LoF allele frequency in 87 
the three major ethnicities of Singapore - Chinese, Malay and Indian. In 279 Chinese 88 
Singaporean samples (see Table E3 in the Online Repository) we identified a further 11 89 













from 22 variants identified in our previous study7) with five not previously reported in the 91 
literature (see Figure 1C and 1D). 85 of these samples had also been previously Sanger 92 
sequenced7 and the concordance profile was near identical (see Table E4 in the Online 93 
Repository). 14 LoF variants reached significance using Fisher’s exact test (p<0.05) compared to 94 
population control data derived from ExAC (version 0.3.1) exome database (see Table E5 and 95 
Supplemental Methods in the Online Repository). The combined FLG LoF mutation allele 96 
frequency for Chinese Singaporean AD patients is now 32.3%, an increase from 20.2% in our 97 
previous survey of 425 patient samples further supporting the biological importance of FLG 98 
mutations in AD7. Smaller cohorts of 19 Indian and 36 Malay patients were analysed and we 99 
identified FLG LoF variants in nine Indian samples and nine Malay samples (See Figure 1D, 100 
Table E6 and Table E7 in the Online Repository). The identification of unreported FLG LoF 101 
variants in Indian and Malay ethnicities from Singapore confirms the diversity of FLG variants 102 
in AD between different ethnic groups. In total we identified 18 variants with limited overlap 103 
with the Chinese samples (4 out of 18) and a number of these are not present in the ExAC 104 
database highlighting the contribution of rare, family-specific mutations in AD (11 of 18). This 105 
small but well characterized study of Indian and Malay Singaporeans highlights the variation in 106 
combined allele frequencies between ethnicities with 47.4% of Indian AD patients and 25% of 107 
Malay AD patients harbouring FLG LoF variants. The presence of FLG LoF variants were 108 
strongly associated with AD, however, were not significantly associated with increasing severity 109 
in the 334 patients analyzed in this study, possibly due to the small number of mild cases 110 
analzyed (mild cases in this cohort 5.3%; see Table E8 in the Online Repository). 111 
In conclusion, we describe a multiplexed targeted resequencing method to study the FLG 112 













genetic contribution from FLG deleterious alleles and CNVs in AD. This strategy to study 114 
genetic variation does not rely on previous mutation spectrum information from any given 115 
population or ethnicity and therefore can identify rare, family-specific or de novo variants 116 
globally. This approach outperforms exome sequencing because of its throughput and ability to 117 
analyse known CNVs that are not currently reflected in NCBI RefSeq version of FLG. Amplicon 118 
resequencing is robust, reliable, unbiased and has the potential for scalable sample preparation 119 
for small and large research or clinical studies, increasing accurate genotyping for improved 120 
outcomes. We have developed a cost-efficient FLG genotyping method (approximately 10 times 121 
cheaper than exome sequencing) for researchers and clinicians studying patients from any 122 
ethnicity that is vital to advance a precision medicine approach to AD. This method can facilitate 123 
research studies immediately and be developed for clinical genetic diagnostics in the future. 124 
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Table 1. Concordance of FLG LoF variant detection for 14 previously fully Sanger-sequenced 208 
AD samples using our MiSeq 2x250 bp protocol. Our NGS protocol detected additional LoF 209 
variants in two samples (red text). 210 
 211 
Sample ID Sanger sequencing Illumina MiSeq 2 x 250 assay 
IA-P003 p.S1515X p.S1515X 
IA-P009 No LoF detected No LoF detected 
IA-P014 No LoF detected No LoF detected 
IA-P017 p.E2422X p.E2422X 
IA-P021 p.S406X; c.6950_6957del8 p.S406X; c.6950_6957del8 
IA-P024 c.1640delG c.1640delG 
IA-P025 p.Q368X; c.3321delA p.Q368X; c.3321delA 
IA-P028 c.7945delA c.7945delA 
IA-P062 p.Q2417X p.Q2417X 
IA-P063 c.2952delC c.2952delC 
IA-P083 c.9040_9058dup19 c.9040_9058dup19; p.Q1790X 
IA-P084 p.S1302X; ND p.S1302X; p.S1515X 
IA-P090 c.4004del2 c.4004del2 
IA-P094 c.2282del4; p.R2447X c.2282del4; p.R2447X 













FIGURE LEGEND 213 
 214 
Figure 1. FLG primer validation, amplicon coverage and FLG LoF variant analysis in 215 
Singaporean AD cohorts (A) 48 FLG-specific primer assays were validated by PCR and gel 216 
electrophoresis to confirm expected amplicon size and absence of non-specific products. (B) 217 
Schematic visualization of overlapping amplicon design across 12-repeat FLG coding region 218 
(green, yellow, red, purple bars). Primer assay 34 (yellow bars), 35 (red bars) and 41 (purple 219 
bars) produced multiple distinct amplicons. (C) Spectrum of disease-associated FLG LoF 220 
variants identified in the Singaporean Chinese IV and/or AD population. 11 additional variants 221 
(highlighted in red) were identified in addition to those from our previous survey, of which 5 222 
variants have not been previously reported (*). (D) Profilaggrin schematic showing LoF FLG 223 
variants domain positions - Singaporean Chinese samples are present above the schematic, 224 
variants not previously reported in Singapore Chinese samples are highlighted (red) including 225 
FLG LoF variants not previously published (*). Positions of FLG LoF variants identified from 226 
Singapore Malays are highlighted in blue and Singapore Indians in green below the schematic. 227 
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Table E1. Primer assays with a maximum amplicon length of 500 base pairs used for multiplexed PCR amplification on 
Access Array IFC prior to Illumina MiSeq 2 x 250 sequencing. Primer assays in red text anneal to multiple regions of FLG 
CNV repeats. Primers assays in blue text have been previously published (Sandilands, et al., 2007). Universal CS1 
(forward; ACACTGACGACATGGTTCTACA) or CS2 (reverse; TACGGTAGCAGAGACTTGGTCT) NGS adaptor 
sequences are synthesized 5’ to the FLG target sequence. 
 
Assay number Primer 
name 





Primer binding location on 




450 Exon 1 
152297567 Intron 3’ to exon 1 
1_R CTGTCAAGCCAAAGTGGGGTTA 152298016 Intron 5’ to exon 1 
2 
2_F AAGAGCTCAAAATAACCCTTGCT 
498 Exon 2 
152287715 Intron 3’ to exon 2 
2_R ACACTGAGGTCTGTGAGACTACT 152288212 Intron 5’ to exon 2 
3 
3_F AGTCTTTCACTTAGCCTCTTCCT 
500 RPT 0 
152286751 RPT 0 
3_R CTCCCTCTGTGACTTCCCTCTG 152287250 5’ to exon 3 
4 
4_F CATCTCTTGACTGCTCCCAC 
500 RPT 0 
152286368 RPT 0 
4_R ACCTACTCATAGAGAAGAAGAATATGGA 152286867 RPT 0 
5 
5_F GTCCAGACCGTTCCCCTGAC 
487 RPT 0 
152285972 RPT 0 
5_R GACAGTGAGGGACACTCAGAAG 152286458 RPT 0 
6 
6_F AAGCTTCATGATGACGTGACCC 
498 RPT 0 & 1 
152285588 RPT 1 
6_R AGGGACATTCAGAAAACTCAGACA 152286085 RPT 0 
7 
7_F CTGCTGACTGGAGCTGGTG 
464 RPT 1 
152285210 RPT 1 
7_R ATCCAGAAGTGCAAGCAGACAAA 152285673 RPT 1 
8 
8_F CTATCTACCGATTGCTCGTGGTG 
483 RPT 1 & 2 
152284774 RPT 2 
8_R AAGTGCAGGAGAAAGACATGGAT 152285256 RPT 1 
9 
9_F CCGGCTCTGTCTTCGTGAT 
500 RPT 2 
152284381 RPT 2 















496 RPT 2 
152283998 RPT 2 
10_R GAAGACTCTGAGAGGTGGTCTGG 152284493 RPT 2 
11 
11_F TAGAGCTGTCAGCCCAAGAGG 
495 RPT 2 & 3 
152283620 RPT 3 
11_R CACAGTCAGTGTCAGGCCAT 152284114 RPT 2 
12 
12_F GTGCCCAATGCCTGAGTGT 
477 RPT 3 
152283237 RPT 3 
12_R AGCAGACAAACTCGTAAGGACAA 152283713 RPT 3 
13 
13_F TCTACTGATTGCTCGTGGTAGGA 
498 RPT 3 & 4 
152282833 RPT 4 
13_R ATCCCATGAACAGGCAAGATCAA 152283330 RPT 3 
14 
14_F CTATCTTCTTGATGGGACCTGGG 
498 RPT 4 
152282443 RPT 4 
14_R AAACAGCTCTAGGCACTCAGCAT 152282940 RPT 4 
15 
15_F CTGGTAGAGGAAAGACCCTGAAC 
471 RPT 4 
152282058 RPT 4 
15_R GAGTCGGCTTCCAGAAACCATTA 152282528 RPT 4 
16 
16_F TTTCTCATTACGTGTTTGTCTGC 
450 RPT 4 & 5 
152281746 RPT 5 
16_R GAGGGACACTCAGAAGAGTCAG 152282195 RPT 4 
17 
17_F TCCATGTCTTTCTCCTGCACTTG 
477 RPT 5 
152281344 RPT 5 
17_R TCCCAGGAAAGGTCTGATGTCT 152281820 RPT 5 
18 
18_F TGAGTCTTCTGAATGTCCCTCAC 
483 RPT 5 
152281200 RPT 5 
18_R AGCTCTAGACACTCGCAGGT 152281682 RPT 5 
19 
19_F TTTCCCTGTGCTGACACTGA 
400 RPT 5 
152281171 RPT 5 
19_R CTGAGAGGTGGTCTGGGTCT 152281570 RPT 5 
20 
20_F TCCAGACCTATCTACCGATTGCT 
485 RPT 5 & 6 
152280876 RPT 6 
20_R CAGGAGAAAGACATGGATCCCAC 152281360 RPT 5 
21 
21_F CTCTGTCTTCGTGATGGGACCT 
480 RPT 6 
152280494 RPT 6 
21_R CATCCCAAGAGGGTCAGGACA 152280973 RPT 6 
22 
22_F GGCGGACTCAGACTGTTCAT 
487 RPT 6 
152280081 RPT 6/7 junction 
22_R AAACCATCATGGATCTGCTCAGG 152280567 RPT 6 























25_R CTGAGAGGTGGTCTGGGTCT 152279623 RPT7 
26 
26_F TCCATGGGAGGACTCAGACT 
489 RPT 7 
152279103 RPT 7/8.1 junction 
26_R CATCATGGATCTGCTCAGGA 152279591 RPT 7 
27 
27_F GTGTCCACGAATGGTGTCCTG 
482 RPT 7 & 8.1 
152278995 RPT 8.1 
27_R GTCACACACAGACTTCCTCTGG 152279476 RPT 7 
28 
28_F GATGTGGTGTGGCTGTGATG 
411 RPT 7 & 8.1 
152278900 RPT 8.1 
28_R CCGAGGGTACAGTGGTAGTCA 152279310 RPT 7 
29 
29_F ACGTGTTGTTCTGCTTGCAC 
483 RPT 7 & 8.1 
152278836 RPT 8.1 
29_R AGTGGACACCGAGGGTACAG 152279318 RPT 7 
30 
30_F TTGTCTGCTTGCACTTCTGG 
477 RPT 7 & 8.1 
152278841 RPT 8.1 
30_R AGTGGACACCGAGGGTACAG 152279318 RPT 7 
31 
31_F GATGGTTTCTGGAAGCAGACCC 
476 RPT 8.1 
152278616 RPT 8.1 
31_R CAGCACTAGAGGAAGACAAGGAT 152279091 RPT 8.1 
32 
32_F CATGACCAGCTCTGCCTTCT 
482 RPT 8.1 
152278541 RPT 8.1 
32_R AGACGGTCAGGACACCATTC 152279022 RPT 8.1 
33 
33_F GTGGGCAGTCAGGATCCAGAA 
403 RPT 8.2 
- RPT 8.2 
33_R GCCTGTCCACCAGAGGAAGC - RPT 8.2 
34 
34_F ACTGACTGTGTGTCTGAGTCTTC 
474 RPT 8.1/8.2/10.2 
152278270 RPT 8.1/8.2/10.2 
34_R AGTCCAGGGACAATCAGAGGG 152278743 RPT 8.1/8.2/10.2 
35 
35_F ATTACGTGTTGTTCTGCTTGCAC 
500 RPT 8.1/8.2/9 
152278833 RPT 8.2 & 9 
35_R CTGCAGTCAGAGACAGTGGAC 152278360 RPT 8.1 & 8.2 
36 
36_F CCAGAGGAAGTCTCTGCGTGA 
468 RPT 9 
152277511 RPT 9 















499 RPT 9 & 10.1 
152277103 RPT 10.1 
37_R CCAGGTCCCATCACGAAGAC 152277601 RPT 9 
38 
38_F TCAGAGTCTTCTGAGTGTCCC 
461 RPT 10.1 
152276704 RPT 10.1 
38_R CATGGGCGGACCAGGA 152277164 RPT 10.1 
39 
39_F TGTCTGGAGCCATCTCTTGA 
400 RPT 10.1 
152276632 RPT 10.1 
39_R GAAGGCAGGGATCCCACT 152277031 RPT 10.1 
40 
40_F CTGTCCGTGGGCTGACAC 
491 RPT 10.1 
152276310 RPT 10.1 
40_R CCGGCCAGGGACAATCAG 152276800 RPT 10.1 
41 
41_F TCATTACGTGTTTCTCTGCTTGC 
499 RPT 10.1/10.2/11 
152275915 RPT 10.2 & 11 





42_R GCTAACACTGGATCCCTGGCG - RPT10.2 
43 
43_F CAGAGAATTCCTCTGGTGGACAGC 
406 RPT 10.2 & 11 
152276149 RPT 10.2 
43_R CGGGATCCTTGTCTTCCTCCAGTA - RPT 11 
44 
44_F ACGATGGTTTCTGGAAGCAG 
411 RPT 11 
152275698 RPT 11 
44_R CAAGAGGGTCAGGACACCAT 152276108 RPT 11 
45 
45_F CCACGTGACTGTATTCCTGAGTG 
486 RPT 11 
152275519 RPT 11 
45_R CCATCACAGCCACACCACAT 152276004 RPT 11 
46 
46_F GAAAGTGAACTTGCTTCATTCTTC  
486 RPT 11  & 3’UTR 
152275119 3'UTR 
46_R TCAGACTCTAGTACCGCTAAGGA 152275604 RPT 11 
47 
47_F GATGTGCTAGCCCTGATGTTGAT 
500 RPT 11  & 3’UTR 
152274758 3' UTR 
47_R CCCAGGTTTATGTGGCCATTCTA 152275257 RPT 11 
48 
48_F CATCTAATTCTGGCCATGGGGAA 
482 3' UTR 
152274569 Intron 3’ to exon 3 














Table E2. FLG LoF mutation profile of the remaining 78 samples in the pilot run 
sequenced with the MiSeq 2x250 bp protocol 
 
S/N Sample ID FLG mutations identified with Illumina MiSeq 2 x 250 assay 
1 ADD1 NJR No LoF detected 
2 ADD1 TCF No LoF detected 
3 AD04 No LoF detected 
4 AD05 YQY No LoF detected 
5 AD06 TGF c.3321delA 
6 AD7 No LoF detected 
7 AD08 No LoF detected 
8 AD09 No LoF detected 
9 AD10 No LoF detected 
10 C04-CX No LoF detected 
11 C03-VH No LoF detected 
12 C01-LRH No LoF detected 
13 EBL-K001 No LoF detected 
14 EBL-K002 No LoF detected 
15 EBL-K003 No LoF detected 
16 EBL-K004 c.1249insG 
17 EBL-K005 No LoF detected 
18 EBL-K009 No LoF detected 
19 EBL-K010 No LoF detected 
20 EBL-K011 No LoF detected 
21 EBL-K013 No LoF detected 
22 EBL-K015 No LoF detected 
23 EBL-K024 No LoF detected 
24 EBL-K025 No LoF detected 
25 EBL-K026 No LoF detected 
26 13-S-K-6 No LoF detected 
27 13-S-K-12 No LoF detected 
28 13-S-K-13 No LoF detected 
29 13-S-K-15 No LoF detected 
30 13-S-K-16 No LoF detected 
31 13-S-K-17 p.K4022X 
32 IA-P102 No LoF detected 
33 IA-P103 No LoF detected 
34 IA-P104 No LoF detected 
35 IA-P105 No LoF detected 
36 IA-P106 No LoF detected 
37 IA-P107 No LoF detected 













 39 IA-P109 c.6834del5 
40 IA-P110 c.5024delC 
41 IA-P111 No LoF detected 
42 IA-P112 No LoF detected 
43 IA-P113 No LoF detected 
44 IA-P114 p.S2706X, p.R826X 
45 IA-P115 p.R2447X, p.R501X 
46 IA-P116 c.4812ins5 
47 IA-P117 No LoF detected 
48 IA-P119 No LoF detected 
49 IA-P120 No LoF detected 
50 IA-P121 No LoF detected 
51 IA-P123 No LoF detected 
52 IA-P124 c.5192_5199dup8 
53 IA-P126 c.3321delA, p.R826X 
54 IA-P127 No LoF detected 
55 IA-P128 No LoF detected 
56 IA-P129 No LoF detected 
57 IA-P130 No LoF detected 
58 IA-P131 No LoF detected 
59 IA-P133 p.R2613X 
60 IA-P135 c.7487delC, c.12856del2 
61 IA-P136 p.Q2123X 
62 IA-P137 No LoF detected 
63 IA-P138 No LoF detected 
64 JOR-RM No LoF detected 
65 IA-P140 No LoF detected 
66 IA-P141 No LoF detected 
67 IA-P142 p.S2344X 
68 IA-P143 c.6950_6957del8 
69 IA-P144 No LoF detected 
70 IA-P148 No LoF detected 
71 IA-P149 p.E2422X 
72 IA-P150 c.6950_6957del8 
73 IA-P151 p.E2422X 
74 IA-P152 p.K4022X 
75 IA-P153 No LoF detected 
76 IA-P155 No LoF detected 
77 IA-P166 p.K4022X 













Table E4. 85 of the 279 Singaporean Chinese AD samples were previously Sanger sequence and these samples have 
now also been sequenced with our microfluidics protocol to check for concordance. One difference was observed and 
highlighted in red text. 
 
S/N Sample ID FLG mutation identified from 
previous Sanger sequencing 
FLG mutation identified from Access 
Array/MiSeq sequencing 
1 IA-P001 No LoF variant detected No LoF variant detected 
2 IA-P002 p.S1515X, c.8393delA p.S1515X, c.8393delA 
3 IA-P003 p.S1515X p.S1515X 
4 IA-P005 No LoF variant detected No LoF variant detected 
5 IA-P006 No LoF variant detected No LoF variant detected 
6 IA-P007 No LoF variant detected No LoF variant detected 
7 IA-P008 No LoF variant detected No LoF variant detected 
8 IA-P009 No LoF variant detected No LoF variant detected 
9 IA-P010 No LoF variant detected No LoF variant detected 
10 IA-P011 No LoF variant detected No LoF variant detected 
11 IA-P013 No LoF variant detected No LoF variant detected 
12 IA-P014 No LoF variant detected No LoF variant detected 
13 IA-P015 No LoF variant detected No LoF variant detected 
14 IA-P016 No LoF variant detected No LoF variant detected 
15 IA-P017 p.E2422X p.E2422X 
16 IA-P018 No LoF variant detected No LoF variant detected 
17 IA-P020 c.9040_9058dup19 c.9040_9058dup19 
18 IA-P021 c.6950_6957del8, p.S406X c.6950_6957del8, p.S406X 
19 IA-P022 No LoF variant detected No LoF variant detected 













21 IA-P024 c.1640delG c.1640delG 
22 IA-P025 c.3321delA, p.Q368X  c.3321delA, p.Q368X 
23 IA-P026 No LoF variant detected No LoF variant detected 
24 IA-P027 No LoF variant detected No LoF variant detected 
25 IA-P028 c.7945delA c.7945delA 
26 IA-P029 No LoF variant detected No LoF variant detected 
27 IA-P030 No LoF variant detected No LoF variant detected 
28 IA-P031 No LoF variant detected No LoF variant detected 
29 IA-P032 No LoF variant detected No LoF variant detected 
30 IA-P033 c.3321delA c.3321delA 
31 IA-P034 p.R4307X, p.S2706X  p.R4307X, p.S2706X 
32 IA-P037 c.3321delA c.3321delA 
33 IA-P038 No LoF variant detected No LoF variant detected 
34 IA-P040 No LoF variant detected No LoF variant detected 
35 IA-P041 No LoF variant detected No LoF variant detected 
36 IA-P042 No LoF variant detected No LoF variant detected 
37 IA-P043 p.S406X, p.Q1745X  p.S406X, p.Q1745X  
38 IA-P044 No LoF variant detected No LoF variant detected 
39 IA-P045 No LoF variant detected No LoF variant detected 
40 IA-P046 No LoF variant detected No LoF variant detected 
41 IA-P047 No LoF variant detected No LoF variant detected 
42 IA-P048 c.3321delA, c.3321delA c.3321delA, c.3321delA 
43 IA-P049 No LoF variant detected No LoF variant detected 
44 IA-P051 No LoF variant detected No LoF variant detected 
45 IA-P052 c.3321delA c.3321delA 













47 IA-P054 No LoF variant detected No LoF variant detected 
48 IA-P055 No LoF variant detected No LoF variant detected 
49 IA-P056 No LoF variant detected No LoF variant detected 
50 IA-P057 No LoF variant detected No LoF variant detected 
51 IA-P058 No LoF variant detected No LoF variant detected 
52 IA-P059 No LoF variant detected No LoF variant detected 
53 IA-P060 c.7945delA c.7945delA 
54 IA-P061 No LoF variant detected No LoF variant detected 
55 IA-P062 p.Q2417X p.Q2417X 
56 IA-P063 c.2952delC c.2952delC 
57 IA-P064 p.S2706X p.S2706X 
58 IA-P065 No LoF variant detected No LoF variant detected 
59 IA-P067 No LoF variant detected No LoF variant detected 
60 IA-P068 No LoF variant detected No LoF variant detected 
61 IA-P069 No LoF variant detected No LoF variant detected 
62 IA-P071 No LoF variant detected No LoF variant detected 
63 IA-P072 No LoF variant detected No LoF variant detected 
64 IA-P073 No LoF variant detected No LoF variant detected 
65 IA-P074 c.3321delA c.3321delA 
66 IA-P075 No LoF variant detected No LoF variant detected 
67 IA-P076 c.3321delA c.3321delA 
68 IA-P077 p.Q2417X p.Q2417X 
69 IA-P078 c.9040_9058dup19, p.G323X               c.9040_9058dup19, p.G323X  
70 IA-P081 No LoF variant detected No LoF variant detected 
71 IA-P082 No LoF variant detected No LoF variant detected 













73 IA-P084 p.S1515X, p.S1302X              p.S1515X, p.S1302X       
74 IA-P085 No LoF variant detected No LoF variant detected 
75 IA-P086 c.3321delA c.3321delA 
76 IA-P087 No LoF variant detected No LoF variant detected 
77 IA-P088 c.3321delA, c.3321delA  c.3321delA, c.3321delA  
78 IA-P089 c.6950_6957del8, p.S2317X c.6950_6957del8, p.S2317X 
79 IA-P090 c.4004del2 c.4004del2 
80 IA-P091 c.3321delA c.3321delA 
81 IA-P092 No LoF variant detected No LoF variant detected 
82 IA-P093 No LoF variant detected No LoF variant detected 
83 IA-P096 c.7249C>T, p.Q2417X c.7249C>T, p.Q2417X 
84 IA-P098 p.E2422X, p.R501X p.E2422X, p.R501X 















Table E5. Fisher’s exact test of Singaporean Chinese FLG-null mutations in the fully sequenced atopic dermatitis (AD) 
cohort of 279 patients compared with ExAC East Asian control data. False discovery rate is shown (FDR). 14 FLG LoF 
mutations reached individual significance of p<0.05 (bold) 
 
FLG mutation Cohort FLG Genotype P-value FDR P-value 
AA Aa aa Total 
c.441delA  AD 277 2 0 279 0.020254 0.049855 
 ExAC (East Asia) 4321 2 0 4323   
c.441del2 AD 278 1 0 279 0.060573 0.084276 
 ExAC (East Asia) 4327 0 0 4327   
c.477insA AD 278 1 0 279 0.060573 0.084276 
 ExAC (East Asia) 4327 0 0 4327   
c.678delA AD 278 1 0 279 0.060573 0.084276 
 ExAC (East Asia) 4327 0 0 4327   
p.G323X AD 276 3 0 279 0.002007 0.008028 
 ExAC (East Asia) 4325 2 0 4327   
p.Q368X AD 278 1 0 279 0.117490 0.134274 
 ExAC (East Asia) 4326 1 0 4327   
p.S378X AD 278 1 0 279 0.117490 0.134274 
 ExAC (East Asia) 4326 1 0 4327   
p.S406X AD 272 7 0 279 0.000012 0.000094 
 ExAC (East Asia) 4319 8 0 4327   
c.1249insG AD 278 1 0 279 0.430429 0.430429 
 ExAC (East Asia) 4319 8 0 4327   
p.R501X AD 278 1 0 279 0.060573 0.084276 
 ExAC (East Asia) 4327 0 0 4327   













 ExAC (East Asia) 4325 2 0 4327   
p.R826X AD 276 3 0 279 0.039975 0.084276 
 ExAC (East Asia) 4317 10 0 4327   
c.2952delC AD 278 1 0 279 0.060573 0.084276 
 ExAC (East Asia) 4327 0 0 4327   
c.3036delT AD 278 1 0 279 0.060573 0.084276 
 ExAC (East Asia) 4327 0 0 4327   
c.3222del4 AD 274 5 0 279 0.003504 0.010638 
 ExAC (East Asia) 4314 13 0 4327   
c.3321delA AD 254 21 2 279 1.90 x 10-8 2.03 x 10-7 
 ExAC (East Asia) 4245 80 2 4327   
p.S1302X AD 276 3 0 279 0.000220 0.001173 
 ExAC (East Asia) 4327 0 0 4327   
c.4004del2 AD 278 1 0 279 0.060573 0.084276 
 ExAC (East Asia) 4327 0 0 4327   
p.S1515X AD 273 6 0 279 0.003112 0.010638 
 ExAC (East Asia) 4308 19 0 4327   
p.Q1745X AD 278 1 0 279 0.060573 0.084276 
 ExAC (East Asia) 4327 0 0 4327   
p.Q1790X AD 278 1 0 279 0.354729 0.378377 
 ExAC (East Asia) 4317 6 0 4327   
c.6950_6957del8 AD 264 15 0 279 3.78 x 10-19 1.21 x 10-17 
 ExAC (East sia) 4327 0 0 4327   
p.Q2417X AD 273 6 0 279 0.000467 0.002137 













p.E2422X AD 273 6 0 279 0.010488 0.027968 
 ExAC (East Asia) 4304 22 1 4327   
p.R2447X AD 278 1 0 279 0.117490 0.134274 
 ExAC (East Asia) 4326 1 0 4327   
c.7945delA AD 276 3 0 279 0.091426 0.121902 
 ExAC (East Asia) 4312 15 0 4327   
p.S2706X AD 271 8 0 279 1.65 x 10-10 2.64 x 10-9 
 ExAC (East Asia) 4327 0 0 4327   
c.8393delA AD 278 1 0 279 0.060573 0.084276 
 ExAC (East Asia) 4327 0 0 4327   
c.9040_9058dup19 AD 276 3 0 279 0.000220 0.001173 
 ExAC (East Asia) 4327 0 0 4327   
c.10866delA AD 278 1 0 279 0.117490 0.134274 
 ExAC (East Asia) 4326 1 0 4327   
p.R4307X AD 277 2 0 279 0.003657 0.010638 
 ExAC (East Asia) 4327 0 0 4327   
p.K4022X AD 272 7 0 279 0.407330 0.420469 














Table E6. 36 Singaporean Malay and 19 Singaporean Indian AD patient demographics and clinical features. NR = 


























1 IA-P019 SAMN06199218 16 Malay Male Moderate 52 66 1 Yes No Yes 
2 IA-P036 SAMN06199139 45 Malay Male Moderate 31.7 42.7 3 No No No 
3 IA-P066 SAMN06199168 28 Malay Female Moderate 39.5 48.5 3 No Yes No 
4 IA-P079 SAMN06199180 21 Malay Male No IV 35.5 44.5 2 Yes No No 
5 IA-P080 SAMN06199181 24 Malay Male No IV 44.5 61.5 2 Yes Yes Yes 
6 IA-P094 SAMN06199195 21 Malay Male Mild 18.5 32.5 3 No No Yes 
7 IA-P099 SAMN06199199 22 Malay Male Mild 19.5 32.5 2 Yes No No 
8 IA-P102 SAMN06199202 21 Malay Male Moderate 55 74 3 Yes No No 
9 IA-P103 SAMN06199203 24 Malay Male Mild 48.5 61.5 1 Yes Yes Yes 
10 IA-P104 SAMN06199204 7 Malay Female Mild 25.1 30.1 1 No No No 













12 IA-P106 SAMN06199206 23 Malay Male Mild 26.1 28.1 1 No No No 
13 IA-P107 SAMN06199207 18 Malay Male No IV 63 77 3 No No No 
14 IA-P108 SAMN06199208 21 Malay Male Mild 59.5 76.5 1 Yes No No 
15 IA-P109 SAMN06199209 19 Malay Male No IV 57 69 3 No No No 
16 IA-P112 SAMN06199212 22 Malay Female No IV 46.5 50.5 3 No No No 
17 IA-P117 SAMN06199217 39 Malay Male Moderate 47 53 2 Yes No No 
18 IA-P124 SAMN06199222 21 Malay Male Mild 32.5 41.5 3 No Yes No 
19 IA-P127 SAMN06199225 20 Malay Female No IV 44 54 3 Yes No No 
20 IA-P128 SAMN06199226 31 Malay Female Mild 65 83 3 Yes No No 
21 IA-P130 SAMN06199228 10 Malay Male Mild 14.2 17.2 3 Yes Yes No 
22 IA-P131 SAMN06199229 21 Malay Male Mild 57 77 3 Yes Yes Yes 
23 IA-P137 SAMN06199233 10 Malay Female Moderate 11.3 28.3 3 No No Yes 
24 IA-P140 SAMN06199235 27 Malay Male No IV 38 45 1 Yes Yes No 
25 IA-P141 SAMN06199236 8 Malay Male Mild 29.2 38.2 3 No No No 
26 IA-P142 SAMN06199237 21 Malay Female Moderate 33.5 40.5 3 Yes Yes No 













28 IA-P144 SAMN06199239 22 Malay Male Severe 60 75 2 No Yes Yes 
29 IA-P148 SAMN06199240 21 Malay Male Moderate 0 11 2 No No No 
30 IA-P155 SAMN06199246 33 Malay Male No IV 49 64 3 No No No 
31 IA-P165 SAMN06199256 18 Malay Male Mild 18.5 20.5 3 No No No 
32 IA-P170 SAMN06199261 12 Malay Male No IV 19.5 36.5 3 Yes Yes No 
33 IA-P181 SAMN06199271 26 Malay Male Moderate 32 51 2 No Yes Yes 
34 IA-P198 SAMN06199288 28 Malay Male No IV 15 31 3 Yes No No 
35 IA-P200 SAMN06199290 28 Malay Male Moderate 33 43 3 Yes Yes No 
36 P016 SAMN06199306 18 Malay Female No IV 60 68 3 Yes Yes No 
37 IA-P004 SAMN06199109 54 Indian Female Severe 42.4 55.4 3 Yes No No 
38 IA-P050 SAMN06199152 19 Indian Male Moderate 36 48 3 Yes Yes No 
39 IA-P095 SAMN06199196 8 Indian Male Mild 54 66 1 No Yes Yes 
40 IA-P101 SAMN06199201 39 Indian Female Mild 24.9 36.9 3 Yes No No 
41 IA-P110 SAMN06199210 17 Indian Male Moderate 48.5 54.5 2 Yes No No 
42 IA-P115 SAMN06199215 18 Indian Male Mild 33.5 39.5 1 Yes Yes No 













44 IA-P119 SAMN06199218 8 Indian Male No IV 55 73 2 Yes Yes Yes 
45 IA-P120 SAMN06199219 10 Indian Male No IV 26.1 36.1 3 No Yes Yes 
46 IA-P121 SAMN06199220 34 Indian Male Severe 52 68 3 No Yes Yes 
47 IA-P123 SAMN06199221 23 Indian Male NR 38 48 3 Yes No No 
48 IA-P125 SAMN06199223 60 Indian Female Moderate 10.7 21.7 3 No No No 
49 IA-P129 SAMN06199227 29 Indian Male Moderate 48 58 3 Yes Yes Yes 
50 IA-P133 SAMN06199230 25 Indian Female Mild 44 63 3 No Yes No 
51 IA-P135 SAMN06199231 8 Indian Female Moderate 50 70 1 Yes Yes Yes 
52 IA-P136 SAMN06199232 13 Indian Female Mild 40.5 51.5 2 No No No 
53 IA-P183 SAMN06199273 32 Indian Male NR 42 55 3 Yes No No 
54 P001 SAMN06199292 8 Indian Male Mild 36 41 2 Yes Yes No 














Table E7. 18 FLG LoF variants identified in Singapore Malay and Indian IV and/or AD 
cohorts using MiSeq 2 x 250 bp protocol. Singaporean Malay and Indian ethnicities have both 
unique and recurrent FLG LoF variants compared to other published studies (see Table E1). * = 
not previously reported LoF variant in AD related published literature. 
 
ID FLG mutation Ethnicity dbSNP ID South Asian ExAC MAF 
East Asian ExAC 
MAF 
1 p.R501X Indian rs61816761 21/16512 0/8654 
2 p.S507X * Malay - Not reported Not reported 
3 c.2282del4 Malay rs558269137 122/16510 0/8654 
4 c.3321delA Malay rs200519781 0/16512 82/8654 
5 p.R1140X Indian - 16/16512 0/8652 
6 c.4812ins5 * Indian - Not reported Not reported 
7 c.5024delC * Indian  rs749542190 Not reported Not reported 
8 c.5187delA * Indian - Not reported Not reported 
9 c.5192_5199dup8 Malay rs754949514 Not reported Not reported 
10 p.Q2123X * Indian rs145119684 8/16512 0/8654 
11 c.6834del5 Malay rs772007167 Not reported Not reported 
12 c.6950del8 Malay; Indian rs578184315  Not reported Not reported 
13 p.S2344X * Malay, Indian rs372754256 Not reported Not reported 
14 c.7333delC Indian - Not reported Not reported 
15 p.R2447X Malay, Indian rs138726443 35/16512 1/8652 
16 c.7487delC * Indian rs375277670 0/16512 5/8650 
17 p.R2613X * Indian rs567795279 Not reported Not reported 















Table E8.  Summary of patient demographics and clinical features of the 3 ethnicities 
studied for FLG LoF variants. SCORAD (SCORing AD) index and objective SCORAD 




Chinese Malay Indian 
Subjects demographics 
Subjects (n) 279 36 19 
Age, mean (range) in years 18.5 (2-70) 22.4 (7-45) 23.6 (8-60) 
Male:female (n) 202:77 28:8 12:7 
Ichthyosis vulgaris 
No ichthyosis vulgaris (n) 103 12 3 
Mild (n) 80 13 6 
Moderate-Severe (n) 84 11 8 
Not recorded (n) 12 0 2 
Number of IV patients with FLG LoF (%) 64 (39.0) 7 (29.2) 8 (57.1) 
Atopic dermatitis 
Mean Total SCORAD (+/- SD) 47.2 (± 17.3) 50.6 (± 19.7) 50.6 (± 13.9) 
Mean oSCORAD 37.6 (± 15.0) 38.8 (± 17.4) 39.4 (± 11.4) 
     No. of Mild AD / oSCORAD <15  (%) 14 (5.1) 3 (8.3) 1 (5.3) 
     No. of Moderate AD / oSCORAD 15-40 (%) 151 (54.9) 16 (44.4) 8 (42.1) 
     No. of Severe AD / oSCORAD >40 (%) 110 (40.0) 17 (47.2) 10 (52.6) 
     IV only, AD not reported (n) 4 0 0 
Mean oSCORAD of samples with FLG LoF 37.5 (± 15.3) 38.9 (± 17.6) 38.2 (± 8.6) 
Mean oSCORAD of samples with WT FLG  37.6 (± 15.0) 38.8 (± 17.4) 40.0 (± 11.3) 
AD Age of onset<5 years age (n) 143 13 8 
AD Age of onset>5 years age (n) 124 23 11 














Table E9. Accession numbers and Biosample IDs for all 367 samples used in this study. 
 Sample_ID Accession number BioSampleID LibraryType 
 IA-P021 SRR5140927 SAMN06199125 MiSeq 2x250bp 
IA-P025 SRR5140721 SAMN06199129 MiSeq 2x250bp 
IA-P062 SRR5140582 SAMN06199164 MiSeq 2x250bp 
IA-P063 SRR5140846 SAMN06199165 MiSeq 2x250bp 
IA-P083 SRR5140660 SAMN06199184 MiSeq 2x250bp 
IA-P102 SRR5140912 SAMN06199202 MiSeq 2x250bp 
IA-P103 SRR5140676 SAMN06199203 MiSeq 2x250bp 
IA-P104 SRR5140639 SAMN06199204 MiSeq 2x250bp 
IA-P105 SRR5140789 SAMN06199205 MiSeq 2x250bp 
IA-P107 SRR5140601 SAMN06199207 MiSeq 2x250bp 
IA-P108 SRR5140555 SAMN06199208 MiSeq 2x250bp 
IA-P111 SRR5140654 SAMN06199211 MiSeq 2x250bp 
IA-P113 SRR5140570 SAMN06199213 MiSeq 2x250bp 
IA-P114 SRR5140746 SAMN06199214 MiSeq 2x250bp 
IA-P116 SRR5140477 SAMN06199216 MiSeq 2x250bp 
IA-P117 SRR5140637 SAMN06199217 MiSeq 2x250bp 
IA-P119 SRR5140686 SAMN06199218 MiSeq 2x250bp 
IA-P123 SRR5140480 SAMN06199221 MiSeq 2x250bp 
IA-P125 SRR5140805 SAMN06199223 MiSeq 2x250bp 
IA-P128 SRR5140719 SAMN06199226 MiSeq 2x250bp 
IA-P130 SRR5140658 SAMN06199228 MiSeq 2x250bp 
IA-P137 SRR5140564 SAMN06199233 MiSeq 2x250bp 
IA-P138 SRR5140932 SAMN06199234 MiSeq 2x250bp 
IA-P140 SRR5140925 SAMN06199235 MiSeq 2x250bp 
IA-P142 SRR5140632 SAMN06199237 MiSeq 2x250bp 
IA-P150 SRR5140759 SAMN06199242 MiSeq 2x250bp 
IA-P151 SRR5140548 SAMN06199105 MiSeq 2x250bp 
IA-P152 SRR5140748 SAMN06199243 MiSeq 2x250bp 
IA-P153 SRR5140921 SAMN06199244 MiSeq 2x250bp 
IA-P154 SRR5140886 SAMN06199245 MiSeq 2x250bp 
ADD1 NJR SRR5140611 SAMN06199086 MiSeq 2x250bp 
AD04 SRR5140648 SAMN06199079 MiSeq 2x250bp 
AD06 TGF SRR5140663 SAMN06199081 MiSeq 2x250bp 
AD10 SRR5140645 SAMN06199084 MiSeq 2x250bp 













EBL-K002 SRR5140549 SAMN06199092 MiSeq 2x250bp 
EBL-K003 SRR5140809 SAMN06199093 MiSeq 2x250bp 
EBL-K004 SRR5140556 SAMN06199094 MiSeq 2x250bp 
EBL-K005 SRR5140839 SAMN06199095 MiSeq 2x250bp 
EBL-K009 SRR5140891 SAMN06199096 MiSeq 2x250bp 
EBL-K010 SRR5140678 SAMN06199097 MiSeq 2x250bp 
EBL-K011 SRR5140613 SAMN06199098 MiSeq 2x250bp 
EBL-K013 SRR5140757 SAMN06199099 MiSeq 2x250bp 
EBL-K015 SRR5140720 SAMN06199100 MiSeq 2x250bp 
EBL-K024 SRR5140741 SAMN06199101 MiSeq 2x250bp 
EBL-K025 SRR5140566 SAMN06199102 MiSeq 2x250bp 
EBL-K026 SRR5140841 SAMN06199103 MiSeq 2x250bp 
13-S-K-6 SRR5140496 SAMN06199078 MiSeq 2x250bp 
13-S-K-12 SRR5140903 SAMN06199073 MiSeq 2x250bp 
13-S-K-15 SRR5140913 SAMN06199075 MiSeq 2x250bp 
13-S-K-17 SRR5140876 SAMN06199077 MiSeq 2x250bp 
IA-P003 SRR5140796 SAMN06199108 MiSeq 2x250bp 
IA-P009 SRR5140847 SAMN06199114 MiSeq 2x250bp 
IA-P014 SRR5140476 SAMN06199118 MiSeq 2x250bp 
IA-P017 SRR5140797 SAMN06199121 MiSeq 2x250bp 
IA-P024 SRR5140900 SAMN06199128 MiSeq 2x250bp 
IA-P028 SRR5140899 SAMN06199132 MiSeq 2x250bp 
IA-P084 SRR5140546 SAMN06199185 MiSeq 2x250bp 
IA-P090 SRR5140836 SAMN06199191 MiSeq 2x250bp 
IA-P094 SRR5140808 SAMN06199195 MiSeq 2x250bp 
ADD1 TCF SRR5140821 SAMN06199087 MiSeq 2x250bp 
AD05 YQY SRR5140801 SAMN06199080 MiSeq 2x250bp 
AD7 SRR5140907 SAMN06199085 MiSeq 2x250bp 
AD08 SRR5140824 SAMN06199082 MiSeq 2x250bp 
AD09 SRR5140684 SAMN06199083 MiSeq 2x250bp 
C04-CX SRR5140634 SAMN06199090 MiSeq 2x250bp 
C03-VH SRR5140861 SAMN06199089 MiSeq 2x250bp 
C01-LRH SRR5140878 SAMN06199088 MiSeq 2x250bp 
13-S-K-13 SRR5140754 SAMN06199074 MiSeq 2x250bp 
13-S-K-16 SRR5140591 SAMN06199076 MiSeq 2x250bp 
IA-P106 SRR5140860 SAMN06199206 MiSeq 2x250bp 
IA-P109 SRR5140872 SAMN06199209 MiSeq 2x250bp 













IA-P112 SRR5140893 SAMN06199212 MiSeq 2x250bp 
IA-P115 SRR5140857 SAMN06199215 MiSeq 2x250bp 
IA-P120 SRR5140606 SAMN06199219 MiSeq 2x250bp 
IA-P121 SRR5140535 SAMN06199220 MiSeq 2x250bp 
IA-P124 SRR5140829 SAMN06199222 MiSeq 2x250bp 
IA-P126 SRR5140705 SAMN06199224 MiSeq 2x250bp 
IA-P127 SRR5140643 SAMN06199225 MiSeq 2x250bp 
IA-P129 SRR5140924 SAMN06199227 MiSeq 2x250bp 
IA-P131 SRR5140790 SAMN06199229 MiSeq 2x250bp 
IA-P133 SRR5140837 SAMN06199230 MiSeq 2x250bp 
IA-P135 SRR5140536 SAMN06199231 MiSeq 2x250bp 
IA-P136 SRR5140763 SAMN06199232 MiSeq 2x250bp 
JOR-RM SRR5140865 SAMN06199104 MiSeq 2x250bp 
IA-P141 SRR5140718 SAMN06199236 MiSeq 2x250bp 
IA-P143 SRR5140704 SAMN06199238 MiSeq 2x250bp 
IA-P144 SRR5140751 SAMN06199239 MiSeq 2x250bp 
IA-P148 SRR5140699 SAMN06199240 MiSeq 2x250bp 
IA-P149 SRR5140583 SAMN06199241 MiSeq 2x250bp 
P046 SRR5140662 SAMN06199336 MiSeq 2x250bp 
P047 SRR5140695 SAMN06199337 MiSeq 2x250bp 
P048 SRR5140621 SAMN06199338 MiSeq 2x250bp 
P049 SRR5140625 SAMN06199339 MiSeq 2x250bp 
P050 SRR5140854 SAMN06199340 MiSeq 2x250bp 
P051 SRR5140739 SAMN06199341 MiSeq 2x250bp 
P052 SRR5140533 SAMN06199342 MiSeq 2x250bp 
P053 SRR5140905 SAMN06199343 MiSeq 2x250bp 
P054 SRR5140698 SAMN06199344 MiSeq 2x250bp 
P055 SRR5140498 SAMN06199345 MiSeq 2x250bp 
P056 SRR5140908 SAMN06199346 MiSeq 2x250bp 
P057 SRR5140775 SAMN06199347 MiSeq 2x250bp 
P058 SRR5140736 SAMN06199348 MiSeq 2x250bp 
P059 SRR5140580 SAMN06199349 MiSeq 2x250bp 
P060 SRR5140910 SAMN06199350 MiSeq 2x250bp 
P061 SRR5140522 SAMN06199351 MiSeq 2x250bp 
P062 SRR5140569 SAMN06199352 MiSeq 2x250bp 
P063 SRR5140523 SAMN06199353 MiSeq 2x250bp 
P064 SRR5140530 SAMN06199354 MiSeq 2x250bp 













P066 SRR5140677 SAMN06199356 MiSeq 2x250bp 
P067 SRR5140525 SAMN06199357 MiSeq 2x250bp 
P068 SRR5140688 SAMN06199358 MiSeq 2x250bp 
P069 SRR5140895 SAMN06199359 MiSeq 2x250bp 
P070 SRR5140487 SAMN06199360 MiSeq 2x250bp 
P071 SRR5140723 SAMN06199361 MiSeq 2x250bp 
P072 SRR5140502 SAMN06199362 MiSeq 2x250bp 
P073 SRR5140520 SAMN06199363 MiSeq 2x250bp 
P074 SRR5140553 SAMN06199364 MiSeq 2x250bp 
P075 SRR5140608 SAMN06199365 MiSeq 2x250bp 
P076 SRR5140618 SAMN06199366 MiSeq 2x250bp 
P077 SRR5140786 SAMN06199367 MiSeq 2x250bp 
P078 SRR5140849 SAMN06199368 MiSeq 2x250bp 
P079 SRR5140691 SAMN06199369 MiSeq 2x250bp 
P080 SRR5140707 SAMN06199370 MiSeq 2x250bp 
P081 SRR5140753 SAMN06199371 MiSeq 2x250bp 
P082 SRR5140479 SAMN06199372 MiSeq 2x250bp 
P083 SRR5140760 SAMN06199373 MiSeq 2x250bp 
P084 SRR5140620 SAMN06199374 MiSeq 2x250bp 
P085 SRR5140706 SAMN06199375 MiSeq 2x250bp 
P086 SRR5140806 SAMN06199376 MiSeq 2x250bp 
P087 SRR5140882 SAMN06199377 MiSeq 2x250bp 
P088 SRR5140902 SAMN06199378 MiSeq 2x250bp 
P089 SRR5140717 SAMN06199379 MiSeq 2x250bp 
P090 SRR5140610 SAMN06199380 MiSeq 2x250bp 
P091 SRR5140799 SAMN06199381 MiSeq 2x250bp 
P092 SRR5140869 SAMN06199382 MiSeq 2x250bp 
P093 SRR5140817 SAMN06199383 MiSeq 2x250bp 
P094 SRR5140930 SAMN06199384 MiSeq 2x250bp 
P095 SRR5140478 SAMN06199385 MiSeq 2x250bp 
P096 SRR5140767 SAMN06199386 MiSeq 2x250bp 
P097 SRR5140835 SAMN06199387 MiSeq 2x250bp 
P098 SRR5140558 SAMN06199388 MiSeq 2x250bp 
P099 SRR5140542 SAMN06199389 MiSeq 2x250bp 
P100 SRR5140843 SAMN06199390 MiSeq 2x250bp 
P101 SRR5140633 SAMN06199391 MiSeq 2x250bp 
P102 SRR5140609 SAMN06199392 MiSeq 2x250bp 













P104 SRR5140694 SAMN06199394 MiSeq 2x250bp 
P105 SRR5140495 SAMN06199395 MiSeq 2x250bp 
P106 SRR5140716 SAMN06199396 MiSeq 2x250bp 
P107 SRR5140896 SAMN06199397 MiSeq 2x250bp 
P108 SRR5140856 SAMN06199398 MiSeq 2x250bp 
P109 SRR5140651 SAMN06199399 MiSeq 2x250bp 
P110 SRR5140769 SAMN06199400 MiSeq 2x250bp 
P111 SRR5140664 SAMN06199401 MiSeq 2x250bp 
P112 SRR5140747 SAMN06199402 MiSeq 2x250bp 
P113 SRR5140894 SAMN06199403 MiSeq 2x250bp 
P114 SRR5140779 SAMN06199404 MiSeq 2x250bp 
P116 SRR5140749 SAMN06199405 MiSeq 2x250bp 
P117 SRR5140537 SAMN06199406 MiSeq 2x250bp 
P118 SRR5140517 SAMN06199407 MiSeq 2x250bp 
P119 SRR5140766 SAMN06199408 MiSeq 2x250bp 
P120 SRR5140571 SAMN06199409 MiSeq 2x250bp 
P122 SRR5140588 SAMN06199410 MiSeq 2x250bp 
P123 SRR5140929 SAMN06199411 MiSeq 2x250bp 
P124 SRR5140825 SAMN06199412 MiSeq 2x250bp 
P125 SRR5140514 SAMN06199413 MiSeq 2x250bp 
P126 SRR5140710 SAMN06199414 MiSeq 2x250bp 
P127 SRR5140626 SAMN06199415 MiSeq 2x250bp 
P129 SRR5140693 SAMN06199416 MiSeq 2x250bp 
P130 SRR5140840 SAMN06199417 MiSeq 2x250bp 
P131 SRR5140541 SAMN06199418 MiSeq 2x250bp 
P132 SRR5140713 SAMN06199419 MiSeq 2x250bp 
P133 SRR5140508 SAMN06199420 MiSeq 2x250bp 
P134 SRR5140490 SAMN06199421 MiSeq 2x250bp 
P135 SRR5140863 SAMN06199422 MiSeq 2x250bp 
P136 SRR5140596 SAMN06199423 MiSeq 2x250bp 
P137 SRR5140787 SAMN06199424 MiSeq 2x250bp 
IA-P001 SRR5140702 SAMN06199106 MiSeq 2x250bp 
IA-P002 SRR5140627 SAMN06199107 MiSeq 2x250bp 
IA-P004 SRR5140731 SAMN06199109 MiSeq 2x250bp 
IA-P005 SRR5140918 SAMN06199110 MiSeq 2x250bp 
IA-P006 SRR5140689 SAMN06199111 MiSeq 2x250bp 
IA-P007 SRR5140915 SAMN06199112 MiSeq 2x250bp 













IA-P010 SRR5140772 SAMN06199115 MiSeq 2x250bp 
IA-P011 SRR5140534 SAMN06199116 MiSeq 2x250bp 
IA-P013 SRR5140906 SAMN06199117 MiSeq 2x250bp 
IA-P015 SRR5140532 SAMN06199119 MiSeq 2x250bp 
IA-P016 SRR5140728 SAMN06199120 MiSeq 2x250bp 
IA-P018 SRR5140674 SAMN06199122 MiSeq 2x250bp 
IA-P019 SRR5140752 SAMN06199123 MiSeq 2x250bp 
IA-P020 SRR5140494 SAMN06199124 MiSeq 2x250bp 
IA-P022 SRR5140834 SAMN06199126 MiSeq 2x250bp 
IA-P023 SRR5140497 SAMN06199127 MiSeq 2x250bp 
IA-P026 SRR5140904 SAMN06199130 MiSeq 2x250bp 
IA-P027 SRR5140579 SAMN06199131 MiSeq 2x250bp 
IA-P029 SRR5140567 SAMN06199133 MiSeq 2x250bp 
IA-P030 SRR5140512 SAMN06199134 MiSeq 2x250bp 
IA-P031 SRR5140700 SAMN06199135 MiSeq 2x250bp 
IA-P032 SRR5140540 SAMN06199136 MiSeq 2x250bp 
IA-P033 SRR5140552 SAMN06199137 MiSeq 2x250bp 
IA-P034 SRR5140712 SAMN06199138 MiSeq 2x250bp 
IA-P036 SRR5140597 SAMN06199139 MiSeq 2x250bp 
IA-P037 SRR5140690 SAMN06199140 MiSeq 2x250bp 
IA-P038 SRR5140701 SAMN06199141 MiSeq 2x250bp 
IA-P040 SRR5140655 SAMN06199142 MiSeq 2x250bp 
IA-P041 SRR5140578 SAMN06199143 MiSeq 2x250bp 
IA-P042 SRR5140500 SAMN06199144 MiSeq 2x250bp 
IA-P043 SRR5140607 SAMN06199145 MiSeq 2x250bp 
IA-P044 SRR5140531 SAMN06199146 MiSeq 2x250bp 
IA-P045 SRR5140871 SAMN06199147 MiSeq 2x250bp 
IA-P046 SRR5140680 SAMN06199148 MiSeq 2x250bp 
IA-P047 SRR5140640 SAMN06199149 MiSeq 2x250bp 
IA-P048 SRR5140647 SAMN06199150 MiSeq 2x250bp 
IA-P049 SRR5140745 SAMN06199151 MiSeq 2x250bp 
IA-P050 SRR5140636 SAMN06199152 MiSeq 2x250bp 
IA-P051 SRR5140811 SAMN06199153 MiSeq 2x250bp 
IA-P052 SRR5140488 SAMN06199154 MiSeq 2x250bp 
IA-P053 SRR5140793 SAMN06199155 MiSeq 2x250bp 
IA-P054 SRR5140683 SAMN06199156 MiSeq 2x250bp 
IA-P055 SRR5140881 SAMN06199157 MiSeq 2x250bp 













IA-P057 SRR5140563 SAMN06199159 MiSeq 2x250bp 
IA-P058 SRR5140848 SAMN06199160 MiSeq 2x250bp 
IA-P059 SRR5140493 SAMN06199161 MiSeq 2x250bp 
IA-P060 SRR5140510 SAMN06199162 MiSeq 2x250bp 
IA-P061 SRR5140732 SAMN06199163 MiSeq 2x250bp 
IA-P064 SRR5140844 SAMN06199166 MiSeq 2x250bp 
IA-P065 SRR5140519 SAMN06199167 MiSeq 2x250bp 
IA-P066 SRR5140780 SAMN06199168 MiSeq 2x250bp 
IA-P067 SRR5140589 SAMN06199169 MiSeq 2x250bp 
IA-P068 SRR5140792 SAMN06199170 MiSeq 2x250bp 
IA-P069 SRR5140851 SAMN06199171 MiSeq 2x250bp 
IA-P071 SRR5140711 SAMN06199172 MiSeq 2x250bp 
IA-P072 SRR5140586 SAMN06199173 MiSeq 2x250bp 
IA-P073 SRR5140889 SAMN06199174 MiSeq 2x250bp 
IA-P074 SRR5140524 SAMN06199175 MiSeq 2x250bp 
IA-P075 SRR5140516 SAMN06199176 MiSeq 2x250bp 
IA-P076 SRR5140599 SAMN06199177 MiSeq 2x250bp 
IA-P077 SRR5140622 SAMN06199178 MiSeq 2x250bp 
IA-P078 SRR5140650 SAMN06199179 MiSeq 2x250bp 
IA-P079 SRR5140768 SAMN06199180 MiSeq 2x250bp 
IA-P080 SRR5140602 SAMN06199181 MiSeq 2x250bp 
IA-P081 SRR5140807 SAMN06199182 MiSeq 2x250bp 
IA-P082 SRR5140897 SAMN06199183 MiSeq 2x250bp 
IA-P085 SRR5140669 SAMN06199186 MiSeq 2x250bp 
IA-P086 SRR5140649 SAMN06199187 MiSeq 2x250bp 
IA-P087 SRR5140819 SAMN06199188 MiSeq 2x250bp 
IA-P088 SRR5140661 SAMN06199189 MiSeq 2x250bp 
IA-P089 SRR5140538 SAMN06199190 MiSeq 2x250bp 
IA-P091 SRR5140614 SAMN06199192 MiSeq 2x250bp 
IA-P092 SRR5140675 SAMN06199193 MiSeq 2x250bp 
IA-P093 SRR5140697 SAMN06199194 MiSeq 2x250bp 
IA-P095 SRR5140788 SAMN06199196 MiSeq 2x250bp 
IA-P096 SRR5140737 SAMN06199197 MiSeq 2x250bp 
IA-P098 SRR5140505 SAMN06199198 MiSeq 2x250bp 
IA-P099 SRR5140830 SAMN06199199 MiSeq 2x250bp 
IA-P100 SRR5140735 SAMN06199200 MiSeq 2x250bp 
IA-P101 SRR5140781 SAMN06199201 MiSeq 2x250bp 













IA-P156 SRR5140667 SAMN06199247 MiSeq 2x250bp 
IA-P157 SRR5140744 SAMN06199248 MiSeq 2x250bp 
IA-P158 SRR5140692 SAMN06199249 MiSeq 2x250bp 
IA-P159 SRR5140722 SAMN06199250 MiSeq 2x250bp 
IA-P160 SRR5140727 SAMN06199251 MiSeq 2x250bp 
IA-P161 SRR5140638 SAMN06199252 MiSeq 2x250bp 
IA-P162 SRR5140815 SAMN06199253 MiSeq 2x250bp 
IA-P163 SRR5140652 SAMN06199254 MiSeq 2x250bp 
IA-P164 SRR5140874 SAMN06199255 MiSeq 2x250bp 
IA-P165 SRR5140544 SAMN06199256 MiSeq 2x250bp 
IA-P166 SRR5140776 SAMN06199257 MiSeq 2x250bp 
IA-P167 SRR5140598 SAMN06199258 MiSeq 2x250bp 
IA-P168 SRR5140884 SAMN06199259 MiSeq 2x250bp 
IA-P169 SRR5140665 SAMN06199260 MiSeq 2x250bp 
IA-P170 SRR5140491 SAMN06199261 MiSeq 2x250bp 
IA-P171 SRR5140709 SAMN06199262 MiSeq 2x250bp 
IA-P172 SRR5140858 SAMN06199263 MiSeq 2x250bp 
IA-P173 SRR5140572 SAMN06199264 MiSeq 2x250bp 
IA-P174 SRR5140888 SAMN06199265 MiSeq 2x250bp 
IA-P175 SRR5140773 SAMN06199266 MiSeq 2x250bp 
IA-P176 SRR5140919 SAMN06199267 MiSeq 2x250bp 
IA-P177 SRR5140916 SAMN06199268 MiSeq 2x250bp 
IA-P178 SRR5140593 SAMN06199269 MiSeq 2x250bp 
IA-P179 SRR5140877 SAMN06199270 MiSeq 2x250bp 
IA-P181 SRR5140922 SAMN06199271 MiSeq 2x250bp 
IA-P182 SRR5140822 SAMN06199272 MiSeq 2x250bp 
IA-P183 SRR5140867 SAMN06199273 MiSeq 2x250bp 
IA-P184 SRR5140826 SAMN06199274 MiSeq 2x250bp 
IA-P185 SRR5140521 SAMN06199275 MiSeq 2x250bp 
IA-P186 SRR5140584 SAMN06199276 MiSeq 2x250bp 
IA-P187 SRR5140750 SAMN06199277 MiSeq 2x250bp 
IA-P188 SRR5140687 SAMN06199278 MiSeq 2x250bp 
IA-P189 SRR5140482 SAMN06199279 MiSeq 2x250bp 
IA-P190 SRR5140630 SAMN06199280 MiSeq 2x250bp 
IA-P191 SRR5140928 SAMN06199281 MiSeq 2x250bp 
IA-P192 SRR5140561 SAMN06199282 MiSeq 2x250bp 
IA-P193 SRR5140529 SAMN06199283 MiSeq 2x250bp 













IA-P195 SRR5140740 SAMN06199285 MiSeq 2x250bp 
IA-P196 SRR5140515 SAMN06199286 MiSeq 2x250bp 
IA-P197 SRR5140595 SAMN06199287 MiSeq 2x250bp 
IA-P198 SRR5140539 SAMN06199288 MiSeq 2x250bp 
IA-P199 SRR5140838 SAMN06199289 MiSeq 2x250bp 
IA-P200 SRR5140898 SAMN06199290 MiSeq 2x250bp 
IA-P201 SRR5140506 SAMN06199291 MiSeq 2x250bp 
P001 SRR5140560 SAMN06199292 MiSeq 2x250bp 
P002 SRR5140615 SAMN06199293 MiSeq 2x250bp 
P003 SRR5140489 SAMN06199294 MiSeq 2x250bp 
P004 SRR5140842 SAMN06199295 MiSeq 2x250bp 
P005 SRR5140483 SAMN06199296 MiSeq 2x250bp 
P006 SRR5140503 SAMN06199297 MiSeq 2x250bp 
P007 SRR5140624 SAMN06199298 MiSeq 2x250bp 
P008 SRR5140783 SAMN06199299 MiSeq 2x250bp 
P009 SRR5140526 SAMN06199300 MiSeq 2x250bp 
P010 SRR5140883 SAMN06199301 MiSeq 2x250bp 
P011 SRR5140623 SAMN06199302 MiSeq 2x250bp 
P013 SRR5140855 SAMN06199303 MiSeq 2x250bp 
P014 SRR5140742 SAMN06199304 MiSeq 2x250bp 
P015 SRR5140527 SAMN06199305 MiSeq 2x250bp 
P016 SRR5140909 SAMN06199306 MiSeq 2x250bp 
P017 SRR5140612 SAMN06199307 MiSeq 2x250bp 
P018 SRR5140880 SAMN06199308 MiSeq 2x250bp 
P019 SRR5140887 SAMN06199309 MiSeq 2x250bp 
P020 SRR5140911 SAMN06199310 MiSeq 2x250bp 
P021 SRR5140803 SAMN06199311 MiSeq 2x250bp 
P022 SRR5140914 SAMN06199312 MiSeq 2x250bp 
P023 SRR5140657 SAMN06199313 MiSeq 2x250bp 
P024 SRR5140866 SAMN06199314 MiSeq 2x250bp 
P025 SRR5140714 SAMN06199315 MiSeq 2x250bp 
P026 SRR5140813 SAMN06199316 MiSeq 2x250bp 
P027 SRR5140616 SAMN06199317 MiSeq 2x250bp 
P028 SRR5140794 SAMN06199318 MiSeq 2x250bp 
P029 SRR5140762 SAMN06199319 MiSeq 2x250bp 
P030 SRR5140600 SAMN06199320 MiSeq 2x250bp 
P031 SRR5140682 SAMN06199321 MiSeq 2x250bp 













P033 SRR5140629 SAMN06199323 MiSeq 2x250bp 
P034 SRR5140810 SAMN06199324 MiSeq 2x250bp 
P035 SRR5140501 SAMN06199325 MiSeq 2x250bp 
P036 SRR5140666 SAMN06199326 MiSeq 2x250bp 
P037 SRR5140708 SAMN06199327 MiSeq 2x250bp 
P038 SRR5140671 SAMN06199328 MiSeq 2x250bp 
P039 SRR5140507 SAMN06199329 MiSeq 2x250bp 
P040 SRR5140890 SAMN06199330 MiSeq 2x250bp 
P041 SRR5140703 SAMN06199331 MiSeq 2x250bp 
P042 SRR5140659 SAMN06199332 MiSeq 2x250bp 
P043 SRR5140603 SAMN06199333 MiSeq 2x250bp 
P044 SRR5140653 SAMN06199334 MiSeq 2x250bp 
P045 SRR5140485 SAMN06199335 MiSeq 2x250bp 
P138 SRR5140551 SAMN06199425 MiSeq 2x250bp 
P140 SRR5140852 SAMN06199426 MiSeq 2x250bp 
P141 SRR5140729 SAMN06199427 MiSeq 2x250bp 
P142 SRR5140605 SAMN06199428 MiSeq 2x250bp 
P143 SRR5140758 SAMN06199429 MiSeq 2x250bp 
P144 SRR5140568 SAMN06199430 MiSeq 2x250bp 
P146 SRR5140725 SAMN06199431 MiSeq 2x250bp 
P147 SRR5140920 SAMN06199432 MiSeq 2x250bp 
P148 SRR5140562 SAMN06199433 MiSeq 2x250bp 
P149 SRR5140668 SAMN06199434 MiSeq 2x250bp 
P150 SRR5140827 SAMN06199435 MiSeq 2x250bp 
P151 SRR5140782 SAMN06199436 MiSeq 2x250bp 
P152 SRR5140543 SAMN06199437 MiSeq 2x250bp 
P157 SRR5140724 SAMN06199438 MiSeq 2x250bp 
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Figure E1. FLG sequencing workflow for Access Array 48.48 IFC and Illumina MiSeq. 
 
Figure E2. Determination of FLG CNV for repeat 8 and 10. (A) The absence of a 
duplication of repeat 10 (repeat 102) manifests as a complete drop in coverage in this 
region (red box). (B) Based on a defined set of coverage ratios, three distinct peaks can 
be generated which corresponds to each repeat 10 CNV status in a set of screened 
samples (Peak 1=10,10; Peak 2=10, 101/102; Peak 3=101/102, 101/102). (C) Repeat 8 
CNV status is correlated with a single nucleotide polymorphism at position c.9645 
(dotted box) of the FLG 12-repeat reference sequence in South-East Asian populations. 
(D) Three distinct peaks corresponding to repeat 8 CNV status of a sample group can be 
















Sample collection  
367 DNA samples were extracted from blood or saliva using standard protocols (Oragene, DNA 
Genotek Inc.; Nucleon Illustra™ BACC2, GE Healthcare). This included 334 patients diagnosed 
with IV and/or AD, clinically scored with SCORAD and collected with local DSRB approval in 
accordance with the Declaration of Helsinki (see Table E9 in the Online Repository) 1. 
 
Access Array 48.48 IFC target-specific primer design 
Primer assays were specifically designed to produce amplicons for Illumina MiSeq 2x250 bp 
read mode sequencing using Reagent Kit-V2. Universal adapter sequences (CS1/CS2) were 
attached to 3’ ends of primers for sample barcoding (see Table E1 in the Online Repository). 
 
PCR-based FLG enrichment with the Access Array 48.48 IFC 
PCR amplification of FLG was performed according to ‘4-Primer Amplicon Tagging on the 
48.48 Access Array IFC’ workflow (Chapter 5 Fluidigm user guide: Access Array System for 
Illumina Sequencing Systems – PN 100-3770 HI, Fluidigm). 
Briefly, for each sample a 5 µL sample mix was prepared containing, (1) 50 ng of DNA 
sample, (2) 2 µM of unique barcoding primer pair (Illumina), (3) FastStart High Fidelity PCR 
reagents (Roche) and (4) dNTP mix (Bioline). 48 individual DNA containing sample mixtures 
were loaded into ‘Sample Inlets’ on the Access Array IFC according to manufacturer’s 
guidelines (see Figure E1 in the Online Repository). Similarly, 48 FLG primer assays were 













Thermocycling of the IFC was completed on Biomark HD PCR machine (Fluidigm) using 
cycling parameters stated in Table 5 Access Array user guide (PN 100-3770 HI, Fluidigm). 
PCR product pools for each individual DNA sample were harvested and quality checked 
(Agilent DNA 1000 kit, Agilent). Samples were purified with Agencourt® AMPure® XP Reagent 
Beads (Beckman Coulter Genomics). Batches containing amplicon pools from 96 or 192 
individual DNA samples were then further combined in a final pool and sequenced on the 
Illumina MiSeq (2 x 250 bp read mode). 
 
Bioinformatics analysis of NGS data 
Sequencing reads were mapped to a FLG reference sequence containing 12 repeats 2. BWA-
MEM (version 0.7.10-r789) was used to map sequencing reads. Mapped reads were stored as 
indexed BAM files and processed with GATK toolkit (v3.4-46-gbc02625, Java version 
1.7.0_75). The HaplotypeCaller module was used to calculate SNVs and indels. Individual 
gVCF files were jointly processed with GenotypeGVCFs module to produce a VCF report for 
multiple samples (same quality cut-offs) to increase the sensitivity of SNV detection 3. VCF files 
were annotated with SnpEff tool (version 4.2) for SNVs and assess their functional impact. 
These analysis steps were chained together with Pipeline Pilot 2016 (Biovia, Dassault Systems) 
for consistent data processing and results storage. 
 
PCR and Sanger-sequencing validation of FLG LoF variants and intragenic CNVs 
FLG LoF variants were validated with Sanger sequencing using previously published primers 2, 4. 
FLG repeat 8 and 10 regions were PCR amplified using Expand High FidelityPLUS PCR System 













5’- GCTTCATGGTGATGCGACCA-3’ 2 and for repeat 10 were 5’-
GGGCCCAGGACAAGCAGGAAC-3’ (in-house designed) and 5’- 
CTGCACTACCATAGCTGCC-3’ 2. Cycle conditions for repeat 8 PCR were: 95 °C enzyme 
activation for 5 min, followed by 36 cycles of denaturation (94 °C for 30 s), annealing (64.7 °C 
for 30 s) and elongation (72 °C for 4 min), followed by a final elongation at 72 °C for 7 min. 
Cycle conditions for repeat 10 PCR were: 95 °C enzyme activation for 5 min, followed by 35 
cycles of denaturation (94 °C for 30 s), annealing (62 °C for 30 s) and elongation (72 °C for 2 
min 30 s), followed by a final elongation at 72 °C for 7 min. Intragenic CNVs were distinguished 
by long-range PCR product sizing on 0.9% w/v agarose gels. 
 
Statistical analysis of FLG  
Allele frequencies were analyzed with Fisher’s exact test using a genotype based model (three 
categories). Population allele frequency control data was extracted from ExAC Database (version 
0.3.1) 5 using the East Asia subset for comparison with Singaporean Chinese patients. South Asia 
and East Asia ExAC subset allele frequency data was provided as control data for the Singapore 
Indian and Malay patients as it was unclear which was the best genetic match. Fisher’s exact test 
was not performed in Malay and Indian cohorts to avoid any over interpretation of results with 
small sample sizes. Analyses were performed in R (v3.3.2) with default settings for the Fisher’s 
exact test function. The association of FLG genotype with AD severity – mild, moderate and 
severe grouping according to oSCORAD 1 – was evaluated both with logistic regression and 
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1 IA-P001 SAMN06199106 36 F Moderate 25.5 39.5 3 No Yes No 
2 IA-P002 SAMN06199107 17 M Severe 39.5 56.5 3 No Yes Yes 
3 IA-P003 SAMN06199108 33 F Moderate 36 48 3 Yes Yes No 
4 IA-P005 SAMN06199110 38 M Moderate 50.5 66.5 3 Yes Yes No 
5 IA-P006 SAMN06199111 30 M Moderate 47 50 3 No No Yes 
6 IA-P007 SAMN06199112 25 F Mild 58 69 1 No No No 
7 IA-P008 SAMN06199113 33 M Moderate 42.5 53.5 3 No Yes Yes 
8 IA-P009 SAMN06199114 25 F No IV 26.1 28.1 4 Yes Yes Yes 
9 IA-P010 SAMN06199115 29 M Mild 49 58 1 Yes No No 
10 IA-P011 SAMN06199116 23 F Moderate 65 85 1 No Yes Yes 
11 IA-P013 SAMN06199117 29 M Mild 23 26 3 No No No 
12 IA-P014 SAMN06199118 57 M Severe 46 53 3 No No No 
13 IA-P015 SAMN06199119 16 M No IV 29 37 1 Yes Yes Yes 
14 IA-P016 SAMN06199120 31 F Moderate 46 53 2 Yes Yes Yes 
15 IA-P017 SAMN06199121 33 M Moderate 44.5 53.5 3 Yes No No 
16 IA-P018 SAMN06199122 22 M Mild 39 47 3 No Yes No 
17 IA-P020 SAMN06199124 20 M Severe 0 0 4 Yes No No 
18 IA-P021 SAMN06199125 14 F Moderate 26.5 32.5 3 No No No 













20 IA-P023 SAMN06199127 27 M Mild 39 49 3 No Yes Yes 
21 IA-P024 SAMN06199128 30 M Moderate 50.5 61.5 2 No Yes No 
22 IA-P025 SAMN06199129 20 M Severe 38.7 42.7 2 Yes Yes No 
23 IA-P026 SAMN06199130 52 F Moderate 39.5 46.5 3 No Yes Yes 
24 IA-P027 SAMN06199131 44 F Severe 47.5 57.5 3 No No No 
25 IA-P028 SAMN06199132 17 M Moderate 57.5 61.5 3 Yes Yes No 
26 IA-P029 SAMN06199133 21 M Moderate 38.9 50.9 3 No No No 
27 IA-P030 SAMN06199134 18 M No IV 28.5 37.5 2 No Yes No 
28 IA-P031 SAMN06199135 21 M No IV 57 69 2 No Yes Yes 
29 IA-P032 SAMN06199136 28 M Moderate 68.5 86.5 3 No Yes No 
30 IA-P033 SAMN06199137 30 M Moderate 37 50 3 No Yes Yes 
31 IA-P034 SAMN06199138 21 M Moderate 39 46 3 No Yes No 
32 IA-P037 SAMN06199140 60 F Severe 46.6 56.6 3 Yes Yes Yes 
33 IA-P038 SAMN06199141 25 F Mild 21.4 27.4 3 No Yes No 
34 IA-P040 SAMN06199142 24 M Mild 62.5 72.5 2 No Yes No 
35 IA-P041 SAMN06199143 22 M Moderate 68.5 80.5 3 No Yes Yes 
36 IA-P042 SAMN06199144 27 F Mild 57.5 68.5 3 Yes Yes No 
37 IA-P043 SAMN06199145 16 F Moderate 24.9 30.9 2 No No No 
38 IA-P044 SAMN06199146 27 M No IV 41.5 51.5 3 No No No 
39 IA-P045 SAMN06199147 18 M Mild 21.6 36.6 2 Yes Yes No 
40 IA-P046 SAMN06199148 41 F Mild 0 0 4 No Yes No 
41 IA-P047 SAMN06199149 34 F Mild 37 45 1 Yes Yes Yes 
42 IA-P048 SAMN06199150 37 M Moderate 44 50 3 Yes No No 
43 IA-P049 SAMN06199151 20 M No IV 65 76 2 No Yes Yes 
44 IA-P051 SAMN06199153 26 M Moderate 68.5 77.5 2 Yes No No 
45 IA-P052 SAMN06199154 24 F Mild 54 70 2 No Yes No 













47 IA-P054 SAMN06199156 28 F Moderate 65 77 3 No No No 
48 IA-P055 SAMN06199157 8 F Mild 24.9 29.9 3 No No No 
49 IA-P056 SAMN06199158 23 M Moderate 43 46 3 No Yes No 
50 IA-P057 SAMN06199159 28 M No IV 40.5 43.5 2 Yes No No 
51 IA-P058 SAMN06199160 31 M No IV 29.6 33.6 3 Yes No No 
52 IA-P059 SAMN06199161 31 M Mild 38 55 3 Yes Yes Yes 
53 IA-P060 SAMN06199162 33 M No IV 34.5 48.5 3 Yes No No 
54 IA-P061 SAMN06199163 22 M No IV 21.4 27.4 3 Yes Yes No 
55 IA-P062 SAMN06199164 23 M No IV 29.6 42.6 3 No Yes No 
56 IA-P063 SAMN06199165 20 M Moderate 39 56 1 Yes No No 
57 IA-P064 SAMN06199166 35 F Mild 24.9 32.9 2 No Yes Yes 
58 IA-P065 SAMN06199167 28 M Mild 21.2 27.2 3 No Yes No 
59 IA-P067 SAMN06199169 22 M Mild 37 42 3 Yes Yes No 
60 IA-P068 SAMN06199170 31 M No IV 47.5 54.5 3 No Yes No 
61 IA-P069 SAMN06199171 20 M No IV 31 40 2 Yes Yes Yes 
62 IA-P071 SAMN06199172 22 M No IV 25.1 42.1 3 Yes Yes No 
63 IA-P072 SAMN06199173 29 M Mild 26.5 43.5 3 Yes Yes No 
64 IA-P073 SAMN06199174 25 M No IV 37.5 43.5 3 No Yes No 
65 IA-P074 SAMN06199175 26 M Severe 25 36 3 No No No 
66 IA-P075 SAMN06199176 33 F No IV 21.6 23.6 3 No No No 
67 IA-P076 SAMN06199177 20 F Moderate 32.5 41.5 3 Yes No No 
68 IA-P077 SAMN06199178 21 M No IV 39 55 3 Yes No No 
69 IA-P078 SAMN06199179 28 M No IV 59.5 75.5 1 No Yes No 
70 IA-P081 SAMN06199182 14 F Mild 33.5 48.5 3 Yes Yes No 
71 IA-P082 SAMN06199183 30 M No IV 44.5 59.5 2 No No Yes 
72 IA-P083 SAMN06199184 21 M Severe 66 82 3 No Yes Yes 













74 IA-P085 SAMN06199186 30 F No IV 68 84 3 No Yes Yes 
75 IA-P086 SAMN06199187 35 M No IV 35.5 40.5 3 No No No 
76 IA-P087 SAMN06199188 21 M No IV 37 45 3 Yes Yes Yes 
77 IA-P088 SAMN06199189 20 M Severe 50 62 3 Yes No No 
78 IA-P089 SAMN06199190 26 F Mild 25.7 29.7 2 No Yes No 
79 IA-P090 SAMN06199191 23 F Mild 25.5 35.5 3 Yes No No 
80 IA-P091 SAMN06199192 10 M Moderate 0 0 4 No No No 
81 IA-P092 SAMN06199193 25 F No IV 31.9 38.9 3 No No No 
82 IA-P093 SAMN06199194 22 M Mild 59 73 3 No No No 
83 IA-P096 SAMN06199197 19 M Moderate 44.5 46.5 2 No No No 
84 IA-P098 SAMN06199198 21 F Severe 0 0 1 No Yes Yes 
85 IA-P100 SAMN06199200 38 M Mild 53 70 3 Yes No No 
86 IA-P111 SAMN06199211 38 F Moderate 46 51 3 No No No 
87 IA-P113 SAMN06199213 17 M Moderate 0 0 3 Yes Yes No 
88 IA-P114 SAMN06199214 14 M Moderate 0 12 NR No Yes Yes 
89 IA-P126 SAMN06199224 31 M NR 47.5 47.5 NR NR NR NR 
90 IA-P138 SAMN06199234 30 M Moderate 44 49 3 Yes Yes No 
91 IA-P149 SAMN06199241 24 M Severe 17.7 34.7 3 No No No 
92 IA-P150 SAMN06199242 27 F NR NR NR 3 No Yes No 
93 IA-P152 SAMN06199243 32 M Mild 37 43 2 Yes No Yes 
94 IA-P153 SAMN06199244 17 M No IV 29 36 3 No No No 
95 IA-P154 SAMN06199245 22 F Mild 32 41 1 No Yes Yes 
96 IA-P156 SAMN06199247 15 M Moderate 27 31 1 No Yes No 
97 IA-P157 SAMN06199248 37 M Severe NR NR 1 No No No 
98 IA-P158 SAMN06199249 38 M Mild 47 58 3 Yes No No 
99 IA-P159 SAMN06199250 37 F Mild 42.5 46.5 1 No No No 













101 IA-P161 SAMN06199252 23 F Moderate 30 35 2 No No No 
102 IA-P162 SAMN06199253 21 M No IV 19.5 27.5 4 No Yes Yes 
103 IA-P163 SAMN06199254 15 F Mild 42.5 60.5 1 No Yes Yes 
104 IA-P164 SAMN06199255 21 M Mild 16 22 3 Yes Yes Yes 
105 IA-P166 SAMN06199257 27 M Moderate 39 54 3 Yes No Yes 
106 IA-P167 SAMN06199258 23 M No IV 60 74 3 No No Yes 
107 IA-P168 SAMN06199259 31 F Moderate 29 43 3 Yes Yes Yes 
108 IA-P169 SAMN06199260 18 M No IV 15 24 3 Yes Yes No 
109 IA-P171 SAMN06199262 22 M Mild 32 39 2 No No No 
110 IA-P172 SAMN06199263 32 M Mild 37.5 49.5 3 No Yes Yes 
111 IA-P173 SAMN06199264 22 M No IV 35.5 51.5 1 Yes Yes Yes 
112 IA-P174 SAMN06199265 50 M Moderate 41 56 1 Yes No No 
113 IA-P175 SAMN06199266 28 M Moderate 46.5 64.5 2 No Yes No 
114 IA-P176 SAMN06199267 21 M Mild 54.5 68.5 2 No No Yes 
115 IA-P177 SAMN06199268 53 M Mild 38 44 3 No Yes Yes 
116 IA-P178 SAMN06199269 21 M No IV 33 53 3 Yes Yes No 
117 IA-P179 SAMN06199270 23 M Mild 38 51 3 Yes No No 
118 IA-P182 SAMN06199272 28 F Mild 16 30 3 Yes Yes Yes 
119 IA-P184 SAMN06199274 21 F Mild 23 26 1 No No No 
120 IA-P185 SAMN06199275 28 M Moderate 37.5 44.5 2 Yes Yes No 
121 IA-P186 SAMN06199276 30 M Severe NR NR NR NR NR NR 
122 IA-P187 SAMN06199277 21 M Mild 0 0 3 No NR NR 
123 IA-P188 SAMN06199278 25 M Severe 27.5 31.5 3 No No No 
124 IA-P189 SAMN06199279 70 M Moderate 26.5 35.5 3 No No No 
125 IA-P190 SAMN06199280 27 M No IV 28.5 36.5 1 Yes Yes Yes 
126 IA-P191 SAMN06199281 22 M Moderate 54 69 3 Yes No No 













128 IA-P193 SAMN06199283 33 M No IV 51.5 62.5 2 No No No 
129 IA-P194 SAMN06199284 24 M No IV NR NR 2 No No No 
130 IA-P195 SAMN06199285 22 M Mild 26.5 42.5 1 No No No 
131 IA-P196 SAMN06199286 28 M Mild 23 39 3 No Yes No 
132 IA-P197 SAMN06199287 32 M Moderate 30.5 38.5 2 Yes No No 
133 IA-P199 SAMN06199289 15 M No IV 26.5 38.5 2 No Yes No 
134 IA-P201 SAMN06199291 28 M No IV NR 52.6 3 No Yes Yes 
135 P002 SAMN06199293 5 M Severe 39 43 1 No Yes No 
136 P003 SAMN06199294 9 M Severe 41 50 1 No No No 
137 P004 SAMN06199295 6 F No IV 51 61 1 Yes Yes No 
138 P005 SAMN06199296 8 F No IV 23 27 3 No No No 
139 P006 SAMN06199297 7 F No IV 54.5 65.5 2 No No No 
140 P007 SAMN06199298 5 M Severe 21.4 31.4 2 No No No 
141 P008 SAMN06199299 10 M Mild 28.8 29.8 2 Yes Yes No 
142 P009 SAMN06199300 9 F Mild 11.5 14.5 2 No No No 
143 P010 SAMN06199301 5 M Mild 21.4 24.4 2 No Yes Yes 
144 P011 SAMN06199302 15 M Moderate 50 52 1 No Yes Yes 
145 P013 SAMN06199303 13 M NR 36.4 40.4 3 No Yes No 
146 P014 SAMN06199304 10 M Severe 70.5 82.5 1 No No No 
147 P015 SAMN06199305 10 F No IV 11.5 16.5 3 No No No 
148 P017 SAMN06199307 13 M Moderate 40.1 49.1 3 Yes Yes No 
149 P018 SAMN06199308 9 F Severe 54.5 62.5 1 No No No 
150 P019 SAMN06199309 5 M Mild 22 27 2 No No No 
151 P020 SAMN06199310 12 F Moderate 39.6 50.6 2 No No No 
152 P021 SAMN06199311 4 F Severe 67 74 1 No No No 
153 P022 SAMN06199312 14 M Moderate 56.1 59.1 3 No No No 













155 P024 SAMN06199314 5 M No IV 41.5 54.5 1 No No No 
156 P025 SAMN06199315 12 M No IV 25.5 38.5 1 No Yes No 
157 P026 SAMN06199316 7 M Moderate 37.5 45.5 1 Yes Yes Yes 
158 P027 SAMN06199317 5 M Moderate 48.9 56.9 2 No Yes No 
159 P028 SAMN06199318 5 M No IV 18.5 26.5 2 No No No 
160 P029 SAMN06199319 7 F No IV 32.5 38.5 2 No No No 
161 P030 SAMN06199320 11 M Mild 37 48 2 Yes Yes Yes 
162 P031 SAMN06199321 5 M Moderate 33.5 43.5 1 Yes No Yes 
163 P032 SAMN06199322 19 M No IV 21.5 32.5 3 Yes No No 
164 P033 SAMN06199323 4 M Severe 67 83 1 No No No 
165 P034 SAMN06199324 11 M Moderate 35.5 37.5 3 Yes Yes No 
166 P035 SAMN06199325 9 M Moderate 34 46 2 No No No 
167 P036 SAMN06199326 12 F No IV 29.5 41.5 1 Yes Yes No 
168 P037 SAMN06199327 19 F Mild 10.9 14.9 3 No Yes No 
169 P038 SAMN06199328 6 M Moderate 26.5 34.5 3 Yes No No 
170 P039 SAMN06199329 8 F NR 7.4 9.4 1 No Yes NR 
171 P040 SAMN06199330 9 F NR 17 23 2 Yes No No 
172 P041 SAMN06199331 10 M No IV 21.4 28.4 3 No Yes Yes 
173 P042 SAMN06199332 17 M No IV 36 48 3 Yes No No 
174 P043 SAMN06199333 17 M No IV 69 80 3 No Yes No 
175 P044 SAMN06199334 11 F NR 23 33 2 No No No 
176 P045 SAMN06199335 13 F No IV 33.1 43.1 3 No Yes No 
177 P046 SAMN06199336 4 M No IV 38.5 54.5 1 No Yes No 
178 P047 SAMN06199337 17 M No IV 50.5 66.5 1 No Yes No 
179 P048 SAMN06199338 8 M No IV 63 73 1 Yes Yes No 
180 P049 SAMN06199339 7 F Mild 21.8 26.8 2 No Yes No 













182 P051 SAMN06199341 16 F No IV 26.5 34.5 3 No Yes Yes 
183 P052 SAMN06199342 9 M NR 52 62 1 No No No 
184 P053 SAMN06199343 4 F NR 36.5 45.5 1 No Yes Yes 
185 P054 SAMN06199344 7 M No IV 53 60 1 No No No 
186 P055 SAMN06199345 20 M Severe 14.4 17.4 4 No Yes No 
187 P056 SAMN06199346 10 M No IV 60 78 2 Yes Yes Yes 
188 P057 SAMN06199347 19 M No IV 33.5 43.5 3 No Yes Yes 
189 P058 SAMN06199348 6 M No IV 49.5 58.5 2 No No No 
190 P059 SAMN06199349 14 M No IV 43.5 48.5 3 No Yes No 
191 P060 SAMN06199350 9 M Mild 25.3 27.3 1 No Yes No 
192 P061 SAMN06199351 5 M Mild 21.6 27.6 1 Yes Yes Yes 
193 P062 SAMN06199352 5 M Mild 42 54 2 No Yes No 
194 P063 SAMN06199353 6 F Mild 35.5 53.5 2 No Yes No 
195 P064 SAMN06199354 19 M Severe 37.5 51.5 1 No Yes No 
196 P065 SAMN06199355 14 M Severe 59.5 69.5 3 No Yes No 
197 P066 SAMN06199356 17 M Mild 56 66 1 No No No 
198 P067 SAMN06199357 10 F Mild 33.1 39.1 2 No Yes Yes 
199 P068 SAMN06199358 5 M No IV 36 46 1 No Yes No 
200 P069 SAMN06199359 11 M Mild 32.5 42.5 3 No Yes Yes 
201 P070 SAMN06199360 15 M No IV 62.5 69.5 3 No Yes No 
202 P071 SAMN06199361 9 M Moderate 50.5 57.5 1 No Yes No 
203 P072 SAMN06199362 19 M Mild 50.1 66.1 3 No Yes No 
204 P073 SAMN06199363 19 M No IV 59.5 68.5 3 No No No 
205 P074 SAMN06199364 19 M Mild 27 35 3 No Yes Yes 
206 P075 SAMN06199365 20 M No IV 68 84 3 No No No 
207 P076 SAMN06199366 20 M No IV 59 75 4 No No No 













209 P078 SAMN06199368 6 M No IV 33.9 47.9 2 No Yes No 
210 P079 SAMN06199369 11 F NR 60 74 1 No Yes No 
211 P080 SAMN06199370 9 M Mild 44.5 58.5 1 No No No 
212 P081 SAMN06199371 6 M No IV 25.5 32.5 2 No Yes Yes 
213 P082 SAMN06199372 20 M No IV 33.5 43.5 3 No Yes No 
214 P083 SAMN06199373 8 M No IV 34.5 39.5 3 Yes No No 
215 P084 SAMN06199374 19 M No IV 57 73 1 Yes Yes Yes 
216 P085 SAMN06199375 8 F No IV 46.5 53.5 2 No Yes No 
217 P086 SAMN06199376 14 F Mild 40.5 46.5 2 No No No 
218 P087 SAMN06199377 17 M No IV 55.2 65.2 1 No Yes No 
219 P088 SAMN06199378 3 F Mild 21.2 23.2 1 Yes Yes No 
220 P089 SAMN06199379 18 M No IV 21.8 26.8 1 No No No 
221 P090 SAMN06199380 3 M Severe 53 69 1 No No No 
222 P091 SAMN06199381 7 F No IV 38.9 50.9 1 No Yes Yes 
223 P092 SAMN06199382 10 M NR 29 41 1 Yes Yes No 
224 P093 SAMN06199383 10 M No IV 31 37 3 No Yes Yes 
225 P094 SAMN06199384 3 M Mild 22 23 1 No No No 
226 P095 SAMN06199385 11 M Mild 49.5 57.5 1 Yes Yes No 
227 P096 SAMN06199386 2 M Mild 42.5 58.5 1 No No No 
228 P097 SAMN06199387 5 M Mild 36.1 49.1 1 No Yes Yes 
229 P098 SAMN06199388 4 F Mild 25.3 39.3 1 No No No 
230 P099 SAMN06199389 12 M Moderate 62.5 68.5 4 No No No 
231 P100 SAMN06199390 11 M No IV 21.4 30.4 2 No Yes No 
232 P101 SAMN06199391 6 M No IV 22 42 2 Yes Yes Yes 
233 P102 SAMN06199392 6 M Mild 18.5 25.5 2 No No No 
234 P103 SAMN06199393 13 M No IV 63 83 3 Yes Yes Yes 













236 P105 SAMN06199395 17 M No IV 53 69 3 Yes Yes Yes 
237 P106 SAMN06199396 15 M Severe 37 44 1 No No No 
238 P107 SAMN06199397 20 M No IV 46.9 62.9 4 No Yes No 
239 P108 SAMN06199398 8 M Mild 25.3 36.3 1 No Yes No 
240 P109 SAMN06199399 13 M No IV 45.6 51.6 3 NR Yes Yes 
241 P110 SAMN06199400 12 M Mild 44 57 1 No Yes No 
242 P111 SAMN06199401 15 M Severe 51 61 1 No Yes No 
243 P112 SAMN06199402 5 M Mild 44 58 2 Yes No No 
244 P113 SAMN06199403 15 F No IV 22 26 3 No Yes Yes 
245 P114 SAMN06199404 5 M No IV 35.5 43.5 2 No No No 
246 P116 SAMN06199405 13 M No IV 25.5 34.5 2 Yes No No 
247 P117 SAMN06199406 16 F Moderate 30 34 1 NR Yes No 
248 P118 SAMN06199407 8 F No IV 21.4 29.4 2 NR Yes No 
249 P119 SAMN06199408 7 F No IV 21.2 31.2 3 NR No No 
250 P120 SAMN06199409 12 F No IV 20.5 34.5 1 Yes Yes No 
251 P122 SAMN06199410 13 M Moderate 35.6 40.6 3 No Yes No 
252 P123 SAMN06199411 4 F No IV 41.3 49.3 1 NR Yes Yes 
253 P124 SAMN06199412 19 M No IV 21.4 35.4 3 Yes Yes No 
254 P125 SAMN06199413 9 M Moderate 55.5 73.5 1 Yes Yes Yes 
255 P126 SAMN06199414 3 M Mild 29.6 41.6 1 Yes No No 
256 P127 SAMN06199415 5 F Mild 42.5 51.5 1 Yes Yes No 
257 P129 SAMN06199416 12 F NR 34.1 46.1 3 No Yes No 
258 P130 SAMN06199417 14 M No IV 40.5 52.5 1 No Yes No 
259 P131 SAMN06199418 2 M Severe 54.5 64.5 1 No No No 
260 P132 SAMN06199419 20 M Mild 34 41 3 Yes Yes No 
261 P133 SAMN06199420 7 F No IV 33.5 45.5 1 Yes Yes Yes 













263 P135 SAMN06199422 19 M Mild 37.5 39.5 3 No Yes No 
264 P136 SAMN06199423 20 M No IV 41 50 3 Yes No No 
265 P137 SAMN06199424 17 M No IV 40 51 1 Yes No No 
266 P138 SAMN06199425 2 M No IV 40.6 52.6 1 No No No 
267 P140 SAMN06199426 6 M No IV 44 61 3 No Yes Yes 
268 P141 SAMN06199427 6 M No IV 2.8 7.8 2 No Yes Yes 
269 P142 SAMN06199428 13 M Mild 59 68 2 No Yes No 
270 P143 SAMN06199429 7 M Mild 40.5 56.5 2 No No No 
271 P144 SAMN06199430 3 F Mild 36.9 49.9 2 No Yes No 
272 P146 SAMN06199431 11 F No IV 35.4 43.4 3 No No No 
273 P147 SAMN06199432 13 M No IV 42.5 57.5 3 No Yes No 
274 P149 SAMN06199434 12 M No IV 32.3 41.3 3 Yes Yes No 
275 P150 SAMN06199435 7 M No IV 29.2 39.2 2 No No No 
276 P151 SAMN06199436 12 M No IV 27.5 39.5 1 Yes No No 
277 P152 SAMN06199437 8 F No IV 47.1 51.1 3 No Yes No 
278 P157 SAMN06199438 14 M Mild 41 54 3 No Yes No 
279 P158 SAMN06199439 17 F Mild 63 73 1 No No No 
 
 
